Keywords: GlaxoSmithKline, Phoenix, M&A, Branded generics, Argentina

GlaxoSmithKline drives into Latin America’s branded generics sector, buying Labs Phoenix for $253 million

Article | 11 June 2010

Print This

UK drugs giant GlaxoSmithKline is extending its reach into emerging markets, revealing yesterday that it buying full control of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in